Concorde Financial’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-58,754
Closed -$2.67M 41
2022
Q4
$2.67M Hold
58,754
1.8% 23
2022
Q3
$2.67M Sell
58,754
-18,441
-24% -$923K 1.8% 23
2022
Q2
$3.44M Sell
77,195
-4,565
-6% -$234K 3.84% 10
2022
Q1
$4.5M Buy
81,760
+15,329
+23% +$800K 2.77% 15
2021
Q4
$3.56M Buy
+66,431
New +$3.43M 2.24% 21

Other funds holding EHC

Concorde Financial's EHC Position: Q1 2023 in Review

Concorde Financial sold out of Encompass Health (EHC) in Q1 2023, closing a stake of 58,754 shares — an estimated $2.67M sold.

Concorde Financial first reported a position in EHC in Q4 2021 and held it in 5 quarters. The position peaked at $4.5M in Q1 2022. 392 funds tracked by Wall St. Rank hold EHC as of Q1 2023.

  • Concorde Financial reported no remaining Encompass Health position as of Q1 2023 after selling out during the quarter.
  • Concorde Financial sold 58,754 Encompass Health shares in Q1 2023, an estimated $2.67M.
  • Concorde Financial first reported a position in Encompass Health in Q4 2021 and held it in 5 quarters.
  • Concorde Financial's Encompass Health position peaked at $4.5M in Q1 2022.
  • 392 funds tracked by Wall St. Rank held Encompass Health as of Q1 2023.

Based on Concorde Financial's 13F filing for Q1 2023, filed 10 May 2023.